The present invention relates to a process for the preparation of the compound N-(3,5-dimethylphenyl)-N'-(2-trifluoromethylphenyl) guanidine of formula (I) which comprises reacting a salt of a compound of formula (II) or a mixture of the salt of the compound of formula (II) and a compound of formula (II) with a compound of formula (III), in the presence of a polar organic solvent; a crystalline solid form of the compound of formula (I), in particular crystalline solid form A; to a pharmaceutical composition comprising them; and to their use as a medicament, in particular to the treatment of a condition mediated by Rho-GTPase cell proteins.
本发明涉及一种制备化合物N-(3,5-二甲基苯基)-N'-(2-三
氟甲基苯基)
脲的方法(式I),其中包括在极性有机溶剂的存在下,将化合物式(II)的盐或化合物式(II)的盐和化合物式(II)的混合物与化合物式(III)反应;化合物式(I)的晶体固态形式,特别是晶体固态形式A;以及包含它们的制药组合物和它们作为药物的用途,特别是用于治疗由Rho-GTP酶细胞蛋白介导的疾病。